stockrowPetros Pharmaceuticals, Inc. (PTPI) vs Redhill Biopharma Ltd. (RDHL)
- Petros Pharmaceuticals, Inc. PTPI 0.00 NaN
- Redhill Biopharma Ltd. RDHL 0.43 0.00%
Petros Pharmaceuticals, Inc. and Redhill Biopharma Ltd. are both Drug Manufacturers Specialty & Generic companies. Redhill Biopharma Ltd. is the larger, with a market value of $3.8M against $1.0M — 3.6× the size. Petros Pharmaceuticals, Inc. grew revenue faster over the last twelve months: −12.2% against −61.9%. Redhill Biopharma Ltd. has the higher net margin (25.2% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Petros Pharmaceuticals, Inc. leads on 8 and Redhill Biopharma Ltd. on 4.
Valuation
Profitability
| Metric | PTPI | RDHL | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 118.32% | 35.16% | 53.51% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 25.20% | (2.31%) |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (710.28%) | 0.00% | (0.80%) |
| Return on assets | (334.15%) | 0.00% | (1.67%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack